# Radiation Oncology/NSCLC/Guidelines

* Front Page: Radiation Oncology | RTOG Trials | Randomized Trials
NSCLC Guidelines
    see also: Palliative Lung Guidelines
National Comprehensive Cancer Network (NCCN)
National Cancer Institute (NCI)
U.S. Preventive Services Task Force
American College of Radiology (ACR)
* Hemoptysis
* Needle Biopsy in the Thorax
* Staging
* Postoperative Adjuvant Therapy
* Induction and Adjuvant Therapy for N2 Disease
* Nonsurgical Aggressive Therapy
* Nonsurgical Poor Performance or Palliative Care
* Follow-Up
* Screening for Pulmonary Metastases
American Brachytherapy Society (ABS)
American College of Chest Physicians (ACCP)
* Chemoprevention
* Screening
* Diagnostic Surgical Pathology
* Evaluation of Pulmonary Nodules
* Treatment of Pulmonary Nodules
* Initial Evaluation of Signs and Symptoms
* Initial Diagnosis
* Physiologic Evaluation
* Noninvasive Staging
* Invasive Mediastinal Staging
* Bronchial Intraepithelial Neoplasia
* Treatment of Stage I and Stage II
* Treatment of Stage IIIA
* Treatment of Stage IIIB
* Treatment of Stage IV
* Special Treatment Issues (e.g. Pancoast, T4N0, solitary mets, etc)
* Bronchioloalveolar Lung Cancer
* Complementary Therapies
* Palliative Care
* Quality of Life, Bereavement
* Chronic Cough Due to Lung Tumors
* Pulmonary Rehabilitation
American Society of Clinical Oncology (ASCO)
* Adjuvant Chemotherapy and Adjuvant Radiotherapy for Resectable Stage I-IIIA (PDF)
* Chemotherapy for Stage IV (PDF)(PMID 19917871)
American Society for Radiation Oncology (ASTRO)
* 2015: Adjuvant PMID 25957185 -- "Adjuvant radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline." (Rodrigues G, Pract Radiat Oncol. 2015 May-Jun;5(3):149-55.)
* 2015: Definitive RT / Loc Adv PMID 25957184 -- "Definitive radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline." (Rodrigues G, Pract Radiat Oncol. 2015 May-Jun;5(3):141-8.)
* 2011: Palliative PMID 25740118 -- "Palliative thoracic radiotherapy in lung cancer: An American Society for Radiation Oncology evidence-based clinical practice guideline." (Rodrigues G, Pract Radiat Oncol. 2011 Apr-Jun;1(2):60-71.)
EORTC
Cancer Care Ontario
* Cross-sectional Imaging
* Role of PET in Diagnosis; Evidence-Based Series
* Postoperative RT in Stage II-IIIA
* Postoperative Chemotherapy +/- RT in Completely Resected Lung Cancer
* Preoperative Chemotherapy +/- Postoperative RT in Technically Resectable Lung Cancer
* Management of Unresectable Stage III; Evidence-Based Series
* Altered Fractionation in Unresectable Lung Cancer
* Role of Brachytherapy in Palliation; Evidence-Based Series
* Role of Photodynamic Therapy
* Chemotherapy in Stage IV
* First-Line Chemotherapy in Stage IV
* Second-Line of Progressive Chemotherapy
* Role of Taxanes in Advanced Stage
* Use of Gemcitabine
* Use of EGFR Inhibitors
National Institute for Clinical Excellence (NICE)
* Full Guideline (2005)
* Photodynamic Therapy for Inorperable Endobronichial Cancer (2005)
* Pemetrexed (2007)
* Bevacizumab (2008))
* Erlotinib (2008)
Scottish Intercollegiate Guidelines Network (SIGN)
British Thoracic Society
All-Ireland Lung Cancer Group